Prostate Adenocarcinoma

general

An adenocarcinoma arising from the prostate gland. It is one of the most common malignant tumors afflicting men. The majority of adenocarcinomas arise in the peripheral zone and a minority occurs in the central or the transitional zone of the prostate gland. Grading of prostatic adenocarcinoma predicts disease progression and correlates with survival. Several grading systems have been proposed, of which the Gleason system is the most commonly used. Gleason sums of 2 to 4 represent well-diff

84

Centers

420

Active Trials

$519M

Cancer Funding

Specific Cancer Types(2)

Top Centers for Prostate Adenocarcinoma(84)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
82.4
2
NCI Comprehensive
High-Volume Research Center
78.2
3
NCI Comprehensive
High-Volume Research Center
73.7
4
NCI Comprehensive
High-Volume Research Center
73.3
5
Active Research Program
69.7
6
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
69.5
7
NCI Comprehensive
Active Research Program
68.9
868.9
9
NCI Comprehensive
Active Research Program
67.5
10
NCI Clinical
Active Research Program
67.5
11
Active Research Program
67.5
12
NCI Comprehensive
Active Research Program
64.5
13
NCI Comprehensive
Active Research Program
64.5
14
NCI Comprehensive
Active Research Program
64.5
15
NCI Comprehensive
Active Research Program
64.5
16
NCI Comprehensive
Active Research Program
64.5
17
NCI Clinical
Active Research Program
64.5
18
Active Research Program
64.5
19
NCI Comprehensive
Active Research Program
63.1
20
NCI Comprehensive
Active Research Program
61.2
21
NCI Comprehensive
Active Research Program
60.7
22
NCI Comprehensive
Active Research Program
60.7
23
NCI Comprehensive
Active Research Program
60.7
24
Active Research Program
60.7
25
Active Research Program
60.7
26
NCI Comprehensive
Active Research Program
59.5
27
NCI Comprehensive
Active Research Program
57.9
28
NCI Comprehensive
Active Research Program
57.0
29
NCI Comprehensive
Active Research Program
55.4
30
NCI Clinical
Active Research Program
54.5
31
NCI Comprehensive
Active Research Program
54.5
32
NCI Comprehensive
Active Research Program
54.5
33
NCI Comprehensive
Active Research Program
54.5
34
Active Research Program
54.5
35
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
54.5
36
NCI Comprehensive
Active Research Program
54.5
37
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
54.5
38
Active Research Program
54.5
39
Active Research Program
54.5
40
Active Research Program
54.5
41
Active Research Program
54.5
42
Active Research Program
54.5
43
Active Research Program
54.5
44
NCI Comprehensive
Active Research Program
52.0
45
NCI Comprehensive
Active Research Program
49.5
46
NCI Comprehensive
Active Research Program
47.7
47
NCI Comprehensive
Active Research Program
47.7
48
NCI Comprehensive
Active Research Program
47.7
49
NCI Comprehensive
Active Research Program
47.7
50
Active Research Program
47.7
51
Active Research Program
47.7
52
Active Research Program
47.7
53
NCI Comprehensive
Active Research Program
46.3
5445.6
55
NCI Comprehensive
Active Research Program
41.2
56
NCI Comprehensive
Active Research Program
41.2
57
NCI Comprehensive
Active Research Program
41.2
58
NCI Comprehensive
Active Research Program
41.2
59
NCI Comprehensive
Active Research Program
41.2
60
NCI Comprehensive
Active Research Program
41.2
61
NCI Clinical
Active Research Program
41.2
62
NCI Comprehensive
Active Research Program
41.2
6341.2
64
Active Research Program
41.2
65
Active Research Program
41.2
66
Active Research Program
41.2
67
NCI Comprehensive
Active Research Program
35.0
68
NCI Clinical
Active Research Program
35.0
69
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
35.0
70
Active Research Program
35.0
71
NCI Comprehensive
Contributing Research Center
30.1
72
NCI Comprehensive
Contributing Research Center
30.1
73
NCI Comprehensive
Contributing Research Center
30.1
74
NCI Comprehensive
Contributing Research Center
30.1
75
NCI Comprehensive
Contributing Research Center
30.1
76
NCI Clinical
Contributing Research Center
30.1
77
NCI Comprehensive
Contributing Research Center
30.1
78
NCI Comprehensive
Contributing Research Center
30.1
79
Contributing Research Center
30.1
80
BC CancerVancouver, BC
Contributing Research Center
30.1
8126.0
82
NCI Comprehensive
26.0
8326.0
84

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →